Condition 1: Endometriosis of uterus. Condition 2: Endometriosis of ovary. Condition 3: Endometriosis of fallopian tube. Condition 4: Endometriosis of pritoneum. Condition 5: Endometriosis of recovagina. Condition 6: Endometriosis of intestine. Endometriosis of uterus Adenomyosis Endometriosis of ovary Endometriosis of fallopian tube Endometriosis of pelvic peritoneum Endometriosis of rectovaginal septum and vagina Endometriosis of intestine
Conditions
Interventions
Intervention 1: Transverse abdominal plane block group receive 0.6 milliliter per kilogram normal saline subcutaneously before incision for Trocar as placebo and at the beginning inject 0.6 milliliter
Treatment - Drugs
Transverse abdominal plane block group receive 0.6 milliliter per kilogram normal saline subcutaneously before incision for Trocar as placebo and at the beginning inject 0.6 milliliter per kilogram Bu
Local infiltration group receive 0.6 milliliter per kilogram Bupivacaine 0.25% subcutaneously at the beginning before skin incision for trocar in four places in equal volume and 0.6 milliliter per kil
Placebo group receive 0.6 milliliter per kilogram normal saline subcutaneously as placebo in four places in equal volume before skin incision for trocar and then 0.6 milliliter per kilogram normal sal
Sponsors
Avicenna Research Institute
Eligibility
Sex/Gender
Female
Age
76 Years to 44 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women between 18 to 50 years old; ASA classification less than 3 ; candidate for elective laparoscopic surgery for endometriosis; take consent for entrance; no addiction to opiate; no companion with other illnesses such as liver, kidney, or psychotic diseases. Exclusion criteria: Tendency of patient for exclusion; allergy to drugs; laparoscopic surgery converted to laparotomy; coagulopathy disease; patients without cooperation; hospitalize less than 24 hours; bowel anastomosis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Severity of post operative pain in 2 to 4 , 6 to 8 , 10 to 12 and 24 hours after surgery. Method of measurement: Ask patients by VNRS scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: 2 to 4, 6 to 8, 10 to 12, and 24 hours after surgery. Method of measurement: Patient expression.;Vomiting. Timepoint: 2 to 4, 6 to 8, 10 to 12, and 24 hours after surgery. Method of measurement: Number of vomiting.;Morphine consumption. Timepoint: 2 to 4, 6 to 8, 10 to 12, and 24 hours after surgery. Method of measurement: miligramme.;Time of first injection of morphine. Timepoint: 2 to 4, 6 to 8, 10 to 12, and 24 hours after surgery. Method of measurement: Hour.;Complication of injection. Timepoint: 2 to 4, 6 to 8, 10 to 12, and 24 hours after surgery. Method of measurement: Yes, No. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoxana Kargar
Avicenna Research Institute
Outcome results
None listed